← The SEC Ephemeris: the whole map
AB Pharmaceuticals, LLC the following drug product: > Efavirenz
In the graph: all 2 documents (4 pages).
- Application
- NDA 210649
- Ticker
- AB Pharmaceuticals, LLC
- Product
- the following drug product: > Efavirenz
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- September 12, 2018 · March 13, 2018
From FDA letters and SEC filings. Not investment or medical advice.